Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(5;14)(q33;q32) PDGFRB::TRIP11

Written1998-02Jean-Loup Huret
Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France

(Note : for Links provided by Atlas : click)


ICD-Morpho 9861/3 AML with mutated NPM1; AML with mutated CEBPA; Acute myeloid leukaemia, NOS
ICD-Morpho 9966/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
Atlas_Id 1118

Clinics and Pathology

Disease yet poorly known: 1 case of AML
Clinics found at relapse with eosinophilia of a M2 AML with t(7;11)


Cytogenetics Morphological so far found as an additional anomaly in a clone bearing a t(7;11)(p15;p15)

Genes involved and Proteins

Gene NamePDGFRB (platelet-derived growth factor receptor, beta polypeptide)
Location 5q32
Protein PDGFRB is the receptor for PDGFB (platelet-derived growth factor-b); membrane protein; belongs to the immunoglobulin superfamily
Gene NameTRIP11 (thyroid hormone receptor interactor 11)
Location 14q32.12
Protein contains a N-term leucine zipper and a C-term putative thyroid hormone receptor interacting domain

Result of the chromosomal anomaly

Hybrid gene
Description 5' CEV14 - 3' PDGFRb
Transcript 10 kb fusion transcript (major) and other (minor) transcripts
Fusion Protein
Description N-term leucine zipper from CEV14 fused to the transmembrane domain and the Tyr kinase domain of PDGFRb in C-term; the reciprocal transcript is not expressed; breakpoints at amino acids 1936 of PDGFRb and 567 of CEV14
Oncogenesis ectopic constitutive tyrosine kinase activation of PDGFRb may occur

To be noted

the above t(5;14)(q33;q32) with PDGFRb and CEV14 rearrangements must not be confused with the t(5;14)(q31;q32) with IL3 and IgH involvements found in ALL.


Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution.
Abe A, Emi N, Tanimoto M, Terasaki H, Marunouchi T, Saito H
Blood. 1997 ; 90 (11) : 4271-4277.
PMID 9373237
Acute myeloblastic leukemia (M2) with translocation (7;11) followed by marked eosinophilia and additional abnormalities of chromosome 5.
Abe A, Tanimoto M, Towatari M, Matsuoka A, Kitaori K, Kato H, Toyozumi H, Takeo T, Adachi K, Emi N
Cancer genetics and cytogenetics. 1995 ; 83 (1) : 37-41.
PMID 7656202


This paper should be referenced as such :
Huret, JL
t(5;14)(q33;q32) PDGFRB/TRIP11
Atlas Genet Cytogenet Oncol Haematol. 1998;2(2):59-59.
Free journal version : [ pdf ]   [ DOI ]
On line version :

Other genes implicated (Data extracted from papers in the Atlas) [ 2 ]


Translocations implicated (Data extracted from papers in the Atlas)

 t(5;14)(q33;q32) PDGFRB/TRIP11

External links

Mitelman databaset(5;14)(q33;q32)
arrayMap (UZH-SIB Zurich)Topo ( C42) Morph ( 9861/3) -   [auto + random 100 samples .. if exist ]   [tabulated segments]
arrayMap (UZH-SIB Zurich)Topo ( C42) Morph ( 9966/3) -   [auto + random 100 samples .. if exist ]   [tabulated segments]
REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed
All articlesautomatic search in PubMed

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Fri Oct 8 16:36:40 CEST 2021

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us